QHSLab, Inc., a digital health company, is in advanced discussions with Catheter Precision, Inc. to restructure its convertible debt previously held by Mercer Street Global Opportunity Fund, LLC. The strategic restructuring aims to enhance QHSLab's financial flexibility and long-term growth outlook by significantly improving its financial position. Key components of the proposed agreement include reducing near-term payment obligations, increasing the conversion price of existing debt instruments, and introducing a payment-in-kind interest option. This initiative is anticipated to improve balance sheet health, reduce dilution risk, and extend the maturity of the notes, allowing the company to focus on growth initiatives. QHSLab expects to finalize and formally announce the agreement in the coming weeks.